Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNA Moderna, Inc.

盘后交易 12-16 18:37:55 EST

29.89

-0.03

-0.10%

盘后29.80

-0.09-0.30%

18:36 EST

最高30.00	最低29.04	成交量734.81万
今开29.91	昨收29.92	日振幅3.21%
总市值116.77亿	流通市值108.59亿	总股本3.91亿
成交额2.18亿	换手率2.02%	流通股本3.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":29.89,"timestamp":1765918800000,"preClose":29.92,"halted":0,"volume":7348110,"hourTrading":{"tag":"盘后","latestPrice":29.8,"preClose":29.89,"latestTime":"18:36 EST","volume":133108,"amount":3978362.51884,"timestamp":1765928189249},"delay":0,"floatShares":363290461,"shares":390679512,"eps":-8.051605,"marketStatus":"盘后交易","change":-0.03,"latestTime":"12-16 18:37:55 EST","open":29.91,"high":30,"low":29.04,"amount":217739224.91244,"amplitude":0.032086,"askPrice":30,"askSize":729,"bidPrice":29.75,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-8.051605,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765933200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":29.92,"preHourTrading":{"tag":"盘前","latestPrice":29.89,"preClose":29.92,"latestTime":"09:29 EST","volume":16303,"amount":484185.177238,"timestamp":1765895399999},"postHourTrading":{"tag":"盘后","latestPrice":29.8,"preClose":29.89,"latestTime":"18:36 EST","volume":133108,"amount":3978362.51884,"timestamp":1765928189249},"volumeRatio":0.7476,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":true,"expireDate":1768539600000,"strike":"35.0","timestamp":1765898639593,"price":0.57,"volume":1250,"amount":71250,"type":"+"}]},"impliedVol":0.683,"impliedVolPercentile":0.212},"requestUrl":"/m/hq/s/MRNA/wiki","defaultTab":"wiki","newsList":[{"id":"1164021921","title":"EMA的CHMP：建议批准Mnexspike的市场授权，用于12岁及以上人群的COVID-19预防","url":"https://stock-news.laohu8.com/highlight/detail?id=1164021921","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164021921?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:36","pubTimestamp":1765546591,"startTime":"0","endTime":"0","summary":"EMA的CHMP：建议批准Mnexspike的市场授权，用于12岁及以上人群的COVID-19预防","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4534","BK4533","BK4532","BK4568","BK4551","BK4139","MRNA","BK4585","BK4588","BK4501"],"gpt_icon":0},{"id":"1190207040","title":"Nanexa Ab - 将获得300万美元的预付款，并有机会获得高达5亿美元的里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1190207040","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190207040?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:36","pubTimestamp":1765402573,"startTime":"0","endTime":"0","summary":"Nanexa Ab - 将获得300万美元的预付款，并有机会获得高达5亿美元的里程碑付款","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4551","BK4533","BK4534","BK4568","BK4501","BK4548","BK4588","BK4139","MRNA","BK4585"],"gpt_icon":0},{"id":"1174468371","title":"Moderna高管表示公司尚未看到与FDA声称COVID疫苗与儿童死亡有关的数据或分析 - 电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1174468371","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174468371?lang=zh_cn&edition=full","pubTime":"2025-12-03 00:36","pubTimestamp":1764693376,"startTime":"0","endTime":"0","summary":"Moderna高管表示公司尚未看到与FDA声称COVID疫苗与儿童死亡有关的数据或分析 - 电话会议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4548","BK4534","BK4533","BK4568","BK4532","MRNA","BK4588","BK4139","BK4551","BK4501"],"gpt_icon":0},{"id":"1186165748","title":"美股疫苗股大跌，FDA 官员提及新冠疫苗与年轻男性心脏疾病有关联","url":"https://stock-news.laohu8.com/highlight/detail?id=1186165748","media":"老虎资讯综合","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186165748?lang=zh_cn&edition=full","pubTime":"2025-12-02 08:25","pubTimestamp":1764635137,"startTime":"0","endTime":"0","summary":"在疫情期间，Prasad 因反对疫苗强制措施以及对新冠疫苗引发心肌炎风险的关注而在网上获得追随者。其他研究则发现，新冠感染导致心肌炎的风险高于接种疫苗。辉瑞和 BioNTech 共同研发了新冠疫苗 Comirnaty。两家公司均研发并销售新冠 mRNA 疫苗。这并非 Prasad 首次推动与 mRNA 新冠疫苗相关的变更。这位 FDA 官员还呼吁为疫苗临床试验设定不同的终点指标。","market":"us","thumbnail":"https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f5a0c542474fbfdd95db309645c9c3a7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"美股疫苗股大跌，FDA 官员提及新冠疫苗与年轻男性心脏疾病有关联","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVAX","PFE","BNTX","MRNA"],"gpt_icon":1},{"id":"1199033044","title":"美股异动 | 疫苗股下跌，Moderna跌超6%！FDA提及儿童死亡与新冠疫苗关联","url":"https://stock-news.laohu8.com/highlight/detail?id=1199033044","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199033044?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:26","pubTimestamp":1764602786,"startTime":"0","endTime":"0","summary":"12月1日，部分美股疫苗股盘中下跌，$Moderna(MRNA)$跌超6%，$诺瓦瓦克斯(NVAX)$跌近4%，$BioNTech(BNTX)$跌超3%。此前$美国食品(USFD)$药物管理局备忘录提及儿童死亡与新冠疫苗的关联。","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f5a0c542474fbfdd95db309645c9c3a7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BNTX","NVAX"],"gpt_icon":0},{"id":"1116171517","title":"异动解读 | FDA备忘录将儿童死亡与疫苗关联，Moderna盘中大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116171517","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116171517?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:16","pubTimestamp":1764602191,"startTime":"0","endTime":"0","summary":"Moderna, Inc.（MRNA）今日盘中大跌5%，引发市场关注。消息面上，美国食品药品监督管理局（FDA）首席医疗和科学官维奈-普拉萨德（Vinay Prasad）在一份备忘录中表示，新冠疫苗接种可能导致至少10名儿童死于心脏炎症。这一发现引发了市场对疫苗安全性的担忧，并可能导致更严格的监管审查。该备忘录基于对2021年至2024年期间96例死亡病例的初步分析，但未透露所涉及的疫苗生产商或儿童的具体健康状况。普拉萨德称这一发现为“深刻的启示”，并宣布了加强疫苗监管的计划。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f5a0c542474fbfdd95db309645c9c3a7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1171006404","title":"异动解读 | FDA备忘录关联儿童死亡，Moderna盘中大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171006404","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171006404?lang=zh_cn&edition=full","pubTime":"2025-12-01 23:16","pubTimestamp":1764602180,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 今日盘中大跌5%，引发市场关注。消息面上，美国食品和药物管理局（FDA）首席医疗和科学官维奈-普拉萨德在一份备忘录中表示，新冠疫苗接种可能导致至少10名儿童死于心脏炎症。这一发现被描述为“深刻的启示”，并促使FDA宣布加强疫苗监管的计划。尽管备忘录未明确提及涉及的疫苗生产商，但市场普遍认为这一消息对Moderna等疫苗制造商的股价产生了负面影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f5a0c542474fbfdd95db309645c9c3a7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"2585319384","title":"接种率越来越低，昔日“明星疫苗股”Moderna成为最被做空的美股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585319384","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585319384?lang=zh_cn&edition=full","pubTime":"2025-11-24 12:10","pubTimestamp":1763957440,"startTime":"0","endTime":"0","summary":"卖空数据公司S3 Partners统计，自9月底以来Moderna一直是标普500指数中被做空最多的股票，2025年卖空者在该公司股票上获得约6.22亿美元的未实现收益。在美国卫生部长Robert F Kennedy Jr数月来的反疫苗言论影响下，市场对疫苗的需求急剧萎缩。","market":"hk","thumbnail":"https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3759965","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3759965","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"gpt_icon":0},{"id":"1100499484","title":"异动解读 | 摩德纳获15亿美元贷款后股价仍大跌5%，投资者对增长前景存疑","url":"https://stock-news.laohu8.com/highlight/detail?id=1100499484","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100499484?lang=zh_cn&edition=full","pubTime":"2025-11-21 02:42","pubTimestamp":1763664147,"startTime":"0","endTime":"0","summary":"生物科技公司摩德纳周四盘中大跌5%，尽管公司宣布获得15亿美元贷款并提出未来增长计划，但投资者似乎对其前景仍持谨慎态度。摩德纳表示已从Ares Management获得一笔15亿美元、为期五年的贷款。摩德纳总裁Stephen Hoge表示，这笔贷款将为公司提供灵活性，用以资助业务拓展或管理风险。然而，摩德纳自疫情带来的巨额收益消退后一直面临财务压力。摩德纳预计2025年销售额仅为16亿至20亿美元，2026年收入增长目标为10%左右。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e9dfbd4d9d200c480e5ae33594ae92e9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1117657613","title":"Moderna获得15亿美元贷款，预计明年营收增长10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117657613","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117657613?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:13","pubTimestamp":1763640806,"startTime":"0","endTime":"0","summary":"11月20日，Moderna盘前涨近3%！公司预计2028年首个流感/新冠组合疫苗将获批上市，2026年收入增长将可达10%。","market":"us","thumbnail":"https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/424a61980d8d04f8172cdf5eafb309c0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e9dfbd4d9d200c480e5ae33594ae92e9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Moderna获得15亿美元贷款，预计明年营收增长10%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA"],"gpt_icon":0},{"id":"1165495390","title":"Moderna：预计2026年现金成本降至约42亿美元，2027年预计现金成本为35亿至39亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165495390","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165495390?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:00","pubTimestamp":1763640014,"startTime":"0","endTime":"0","summary":"Moderna：预计2026年现金成本降至约42亿美元，2027年预计现金成本为35亿至39亿美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4534","BK4533","BK4501","BK4139","MRNA","BK4568","BK4588","BK4551","BK4585","BK4532"],"gpt_icon":0},{"id":"1192043294","title":"Moderna：预计2028年将继续保持势头，期待季节性诺如病毒疫苗的审批","url":"https://stock-news.laohu8.com/highlight/detail?id=1192043294","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192043294?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:00","pubTimestamp":1763640014,"startTime":"0","endTime":"0","summary":"Moderna：预计2028年将继续保持势头，期待季节性诺如病毒疫苗的审批","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4585","BK4588","BK4533","BK4534","BK4568","BK4532","BK4551","MRNA","BK4139","BK4548"],"gpt_icon":0},{"id":"1175957517","title":"Moderna预计到2028年将季节性疫苗产品从三款扩展至多六款","url":"https://stock-news.laohu8.com/highlight/detail?id=1175957517","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175957517?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:00","pubTimestamp":1763640013,"startTime":"0","endTime":"0","summary":"Moderna预计到2028年将季节性疫苗产品从三款扩展至多六款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4534","BK4585","BK4568","MRNA","BK4548","BK4551","BK4532","BK4139","BK4501","BK4533"],"gpt_icon":0},{"id":"1196043098","title":"Moderna第三季度每股收益为-0.51美元，预测为-2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196043098","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196043098?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571479,"startTime":"0","endTime":"0","summary":"11月6日——Moderna第三季度收入为10亿美元，高于IBES预估的8.865亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4568","BK4585","BK4139","BK4534","BK4588","MRNA","BK4532","BK4551","BK4501","BK4548"],"gpt_icon":0},{"id":"1126957565","title":"Moderna在Mtc的新药物产品制造能力建设已启动，预计2027年上半年完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1126957565","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126957565?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:18","pubTimestamp":1763554698,"startTime":"0","endTime":"0","summary":"Moderna在Mtc的新药物产品制造能力建设已启动，预计2027年上半年完成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4548","BK4139","BK4585","BK4588","BK4501","BK4533","BK4551","BK4532","BK4534","MRNA"],"gpt_icon":0},{"id":"1171025253","title":"Moderna 超过 1.4 亿美元投资将创造数百个高技能生物制造职位","url":"https://stock-news.laohu8.com/highlight/detail?id=1171025253","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171025253?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:17","pubTimestamp":1763554636,"startTime":"0","endTime":"0","summary":"Moderna 超过 1.4 亿美元投资将创造数百个高技能生物制造职位","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4585","BK4588","BK4533","BK4534","BK4568","BK4532","BK4551","MRNA","BK4139","BK4548"],"gpt_icon":0},{"id":"1169913667","title":"异动解读 | Moderna盘前大涨5.86%，拟于2025年重新提交Mrna-1083至加拿大卫生部","url":"https://stock-news.laohu8.com/highlight/detail?id=1169913667","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169913667?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:03","pubTimestamp":1762430601,"startTime":"0","endTime":"0","summary":"生物技术公司Moderna, Inc.（MRNA）今日盘前股价大涨5.86%，引发投资者关注。\n\n消息面上，Moderna公司宣布计划于2025年向加拿大卫生部重新提交Mrna-1083产品。同时，公司表示正在等待美国食品药品监督管理局（FDA）的进一步指导。这一消息显示了公司在产品开发和监管审批方面的积极进展。\n\nMrna-1083的重新提交计划表明Moderna正在积极推进其产品管线，这可能增强了投资者对公司未来增长潜力的信心。此外，公司与美国FDA的持续沟通也显示了其在监管合规方面的努力。这些因素综合作用，可能是推动Moderna股价在盘前大幅上涨的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0},{"id":"1100204306","title":"Moderna：预计将在2025年向加拿大卫生部重新提交Mrna-1083，等待美国FDA的进一步指导","url":"https://stock-news.laohu8.com/highlight/detail?id=1100204306","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100204306?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:00","pubTimestamp":1762430431,"startTime":"0","endTime":"0","summary":"Moderna：预计将在2025年向加拿大卫生部重新提交Mrna-1083，等待美国FDA的进一步指导。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4532","BK4501","BK4548","BK4588","MRNA","BK4585","BK4551","BK4534","BK4139","BK4533"],"gpt_icon":0},{"id":"2579493814","title":"莫德纳周五早盘下跌4.1%，部分回吐昨日涨幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2579493814","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579493814?lang=zh_cn&edition=full","pubTime":"2025-10-31 22:28","pubTimestamp":1761920880,"startTime":"0","endTime":"0","summary":"美股周五早盘，莫德纳（MRNA）股价下跌4.1%，部分回吐了昨日高达13.9%的涨幅。周四有报道称，该公司正与至少一家大型制药商就潜在的收购交易进行谈判，推动当天该股飙升。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-10-31/doc-infvvcyf8441524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","BK4532","BK4534","BK4548","BK4568","SINA","BK4551","BK4501","MRNA","BK4533","BK4585","BK4588"],"gpt_icon":0},{"id":"1104887341","title":"异动解读 | 传与大型制药商进行收购谈判，Moderna盘中大涨9.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104887341","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104887341?lang=zh_cn&edition=full","pubTime":"2025-10-30 23:51","pubTimestamp":1761839468,"startTime":"0","endTime":"0","summary":"周四盘中，生物科技公司Moderna（MRNA）股价出现显著上涨，涨幅高达9.39%，引发市场广泛关注。截至发稿时，该公司股价报26.95美元。\n\n据熟悉情况的消息人士透露，Moderna目前正与至少一家大型制药公司就潜在的大规模收购交易进行谈判。这一消息激发了投资者的热情，推动了公司股价的快速上涨。尽管具体细节尚未公开，但市场普遍认为，如果收购成功，将有助于Moderna进一步扩大其在生物制药领域的影响力，并可能带来协同效应，从而增强公司的竞争优势。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MRNA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.modernatx.com","stockEarnings":[{"period":"1week","weight":0.0697},{"period":"1month","weight":0.2079},{"period":"3month","weight":0.2045},{"period":"6month","weight":0.178},{"period":"1year","weight":-0.2847},{"period":"ytd","weight":-0.2804}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸（信使核糖核酸）医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年，该公司以前所未有的速度和效率开发出药物，包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队，以负责任的方式改变人类健康的未来，该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.057743},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.012362},{"month":3,"riseRate":0.571429,"avgChangeRate":0.028598},{"month":4,"riseRate":0.714286,"avgChangeRate":0.123955},{"month":5,"riseRate":0.571429,"avgChangeRate":0.06219},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.025027},{"month":7,"riseRate":0.714286,"avgChangeRate":0.106584},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.089569},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.018964},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.032236},{"month":11,"riseRate":0.714286,"avgChangeRate":0.206001},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.03091}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}